Skip to main content
. 2021 Feb 11;17:106–110. doi: 10.1016/j.phro.2021.02.001

Table 2.

Doses (EQD2) with and without hippocampal-sparing stereotactic radiosurgery (HS-SRS).

Mean dose without HS-SRS (EQD2, Gy) (range) Mean dose with HS-SRS (EQD2, Gy) (range) Dose reduction with HS-SRS (EQD2, Gy) (range) Dose reduction with HS-SRS (%) P-value
Dmin 0.4 (0.0–3.1) 0.3 (0–2.0) 0.1 (0–2.53) 35 <0.02
D40 1.8 (0.0–7.0) 0.9 (0.0–4.9) 0.9 (0–5.5) 50 <0.001
Dmean 1.6 (0.05–6.71) 0.8 (0.03–4.04) 0.8 (0–5.31) 52 <0.001
Dmax 8.2 (0.1–48.1) 3.6 (0.1–32.5) 4.5 (0.0–17.0) 55 <0.001